相似文献
1
Usefulness of Adjunctive Fecal Calprotectin and Serum Procalcitonin in Individuals Positive for Clostridium difficile Toxin Gene by PCR Assay.
J Clin Microbiol. 2015 Nov;53(11):3667-9. doi: 10.1128/JCM.02230-15. Epub 2015 Sep 9.
2
Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates.
J Clin Microbiol. 2006 Feb;44(2):353-8. doi: 10.1128/JCM.44.2.353-358.2006.
3
4
Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
Am J Trop Med Hyg. 2008 Aug;79(2):164-5.
5
Clostridium difficile PCR Cycle Threshold Predicts Free Toxin.
J Clin Microbiol. 2017 Sep;55(9):2651-2660. doi: 10.1128/JCM.00563-17. Epub 2017 Jun 14.
6
Detection of toxigenic Clostridium difficile in stool specimens by the polymerase chain reaction.
J Infect Dis. 1993 Feb;167(2):455-8. doi: 10.1093/infdis/167.2.455.
7
Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
Anaerobe. 2009 Dec;15(6):266-9. doi: 10.1016/j.anaerobe.2009.09.008. Epub 2009 Sep 20.
8
Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
J Clin Microbiol. 2004 Dec;42(12):5710-4. doi: 10.1128/JCM.42.12.5710-5714.2004.
9
Evaluation of Nested Polymerase Chain Reaction and Immunoassay for Rapid Diagnosis of Clostridium difficile in Children with Community Acquired Diarrhea.
Clin Lab. 2017 Feb 1;63(2):321-326. doi: 10.7754/Clin.Lab.2016.160606.
10
Pseudomembranous colitis caused by toxin A-negative/toxin B-positive variant strain of Clostridium difficile.
J Infect Chemother. 2003 Dec;9(4):351-4. doi: 10.1007/s10156-003-0269-z.
引用本文的文献
1
Diagnostic Guidance for C. difficile Infections.
Adv Exp Med Biol. 2024;1435:33-56. doi: 10.1007/978-3-031-42108-2_3.
2
Microbiome profile and calprotectin levels as markers of risk of recurrent infection.
Front Cell Infect Microbiol. 2023 Sep 13;13:1237500. doi: 10.3389/fcimb.2023.1237500. eCollection 2023.
3
Overview of current detection methods and microRNA potential in infection screening.
World J Gastroenterol. 2023 Jun 14;29(22):3385-3399. doi: 10.3748/wjg.v29.i22.3385.
4
Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic .
J Clin Med. 2021 Apr 12;10(8):1627. doi: 10.3390/jcm10081627.
5
Laboratory Tests for the Diagnosis of .
Clin Colon Rectal Surg. 2020 Mar;33(2):73-81. doi: 10.1055/s-0039-3400476. Epub 2020 Feb 25.
6
Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection.
Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2341-2346. doi: 10.1007/s10096-018-3381-9. Epub 2018 Sep 21.
7
Faecal lactoferrin and calprotectin in patients with Clostridium difficile infection: a case-control study.
Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2423-2430. doi: 10.1007/s10096-017-3080-y. Epub 2017 Aug 12.
8
Current knowledge on the laboratory diagnosis of infection.
World J Gastroenterol. 2017 Mar 7;23(9):1552-1567. doi: 10.3748/wjg.v23.i9.1552.
本文引用的文献
1
Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
Frontline Gastroenterol. 2015 Jan;6(1):14-19. doi: 10.1136/flgastro-2013-100420. Epub 2014 Mar 17.
2
Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study.
PLoS One. 2014 Aug 29;9(8):e106118. doi: 10.1371/journal.pone.0106118. eCollection 2014.
3
Clinical characteristics and outcome of patients with Clostridium difficile infection diagnosed by PCR versus a three-step algorithm.
Clin Microbiol Infect. 2014 Oct;20(10):1067-73. doi: 10.1111/1469-0691.12676. Epub 2014 Jul 12.
4
Is there any value in measuring faecal calprotectin in Clostridium difficile positive faecal samples?
J Med Microbiol. 2014 Apr;63(Pt 4):590-593. doi: 10.1099/jmm.0.067389-0. Epub 2014 Jan 25.
5
The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Surg Infect (Larchmt). 2013 Dec;14(6):489-511. doi: 10.1089/sur.2012.028. Epub 2013 Nov 25.
6
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.
Lancet Infect Dis. 2013 Nov;13(11):936-45. doi: 10.1016/S1473-3099(13)70200-7. Epub 2013 Sep 3.
7
Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.
BMC Infect Dis. 2013 Mar 25;13:148. doi: 10.1186/1471-2334-13-148.
8
Procalcitonin levels associate with severity of Clostridium difficile infection.
PLoS One. 2013;8(3):e58265. doi: 10.1371/journal.pone.0058265. Epub 2013 Mar 7.
9
Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program.
Clin Infect Dis. 2013 Jan;56(1):67-73. doi: 10.1093/cid/cis840. Epub 2012 Sep 25.
10
Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea.
Am J Med. 2008 Dec;121(12):1099-106. doi: 10.1016/j.amjmed.2008.06.034.
Zotero 插件